Execution RiskNuScale's valuation already prices in significant future success, but the company faces higher execution risk and a more distant cash flow profile.
Financial PerformanceSMR reported revenue of ~$8M, coming below consensus of ~$11M, down ~40% sequentially.
Project VisibilityNuScale’s only active project has been pushed to a late-2026 FID and early-2030s operations, leaving limited near-term visibility.